During the 2-year follow-up, there were significantly fewer cardiovascular events in patients treated with amlodipine than in those receiving placebo (16.6% vs 23.1% of patients, respectively ...
Objectives Most patients with hypertension require more than one drug to attain recommended blood pressure (BP) targets. Initiating therapy with two agents is recommended for patients at high risk of ...
Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...
≤95mm Hg were randomised to receive amlodipine 5 mg/day or hydrochlorothiazide 50 mg/day for 8 weeks (phase II). After 4 weeks of active treatment, if sitting SBP (sSBP) still was above 150mm Hg ...
during which time he was started on amlodipine. Additional medications include lisonipril, allopuriniol, venlafaxine and talvaptan. Given the patient’s presenting features in combination with lack of ...
to Amlodipine 2.5 mg plus Bisoprolol Fumarate USP 5 mg, is considered rational by the Prof ... blood pressure control in patients with essential hypertension following monotherapy failure. Bisoprolol ...
The trial, which was simultaneously published in JACC, randomized participants in a 2:2:1 ratio to GMRx2 1/4 dose (telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg), GMRx2 1/2 dose ...